Advanced Search

    Technical Analysis for MLYS - Mineralys Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 15.66 0.06% 0.01
    MLYS closed up 0.06 percent on Friday, March 31, 2023, on 51 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong N/A N/A Up
    Historical MLYS trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion 0.06%
    Wide Bands Range Expansion 5.45%
    1,2,3 Retracement Bearish Bearish Swing Setup 5.31%
    Outside Day Range Expansion 5.31%
    Wide Bands Range Expansion 5.31%
    Wide Bands Range Expansion -1.94%
    Inside Day Range Contraction 3.50%
    Wide Bands Range Expansion 3.50%
    Oversold Stochastic Weakness 3.50%
    Older End-of-Day Signals for MLYS ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    10 DMA Support 1 day ago
    Down 3% 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    Rose Above 10 DMA 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MLYS Chart by TradingView
    Basic chart:

    Profile

    Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension Aldosterone Synthase

    Is MLYS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 29 Mineralys Therapeutics (MLYS) Investor Presentation - Slideshow
    Mar 16 Where Mineralys Therapeutics Stands With Analysts
    Mar 15 GAAP EPS of -$1.74 misses by $0.02
    Mar 15 Mineralys Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
    Mar 7 Mineralys gains as Wells Fargo, Stifel issue bullish ratings citing lead asset
    Mar 4 Mineralys Therapeutics Presents Positive Lorundrostat Results from the Phase 2 Target-HTN Trial at ACC.23/WCC
    Mar 4 Stocks To Watch: Jobs Report Drama Could Flip The Script For Investors
    Mar 1 Mineralys Therapeutics to Announce Fourth Quarter 2022 Financial Results and Host Conference Call on Wednesday, March 15, 2023
    Feb 20 Mineralys Therapeutics Abstracts Selected to be Presented at the American College of Cardiology Annual Scientific Session & Expo Together with the World Congress of Cardiology (ACC.23/WCC) in March 2023
    Feb 17 Lab Notes: AnPac dips into real estate with diversification strategy; Mineralys closes $220.8M IPO
    See more MLYS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.98
    52 Week Low 13.545
    Average Volume 262,372
    200-Day Moving Average 0.00
    50-Day Moving Average 0.00
    20-Day Moving Average 15.97
    10-Day Moving Average 15.12
    Average True Range 1.18
    RSI 45.05
    ADX 30.48
    +DI 13.61
    -DI 21.16
    Chandelier Exit (Long, 3 ATRs) 16.56
    Chandelier Exit (Short, 3 ATRs) 17.08
    Upper Bollinger Bands 18.37
    Lower Bollinger Band 13.57
    Percent B (%b) 0.44
    BandWidth 30.08
    MACD Line -0.74
    MACD Signal Line -0.83
    MACD Histogram 0.0857
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 16.76
    Resistance 3 (R3) 16.70 16.26 16.58
    Resistance 2 (R2) 16.26 15.98 16.30 16.52
    Resistance 1 (R1) 15.96 15.81 16.11 16.03 16.46
    Pivot Point 15.53 15.53 15.60 15.56 15.53
    Support 1 (S1) 15.23 15.25 15.38 15.29 14.86
    Support 2 (S2) 14.79 15.07 14.83 14.80
    Support 3 (S3) 14.49 14.79 14.74
    Support 4 (S4) 14.56